Our study is the first to present a landscape of expression of PD-L1/L2 and PD-1 in endometrial tumor tissues resolved into tumor cells and cells of the TME, including lymphocytes, macrophages, tumor-associated blood vessels, and CAFs in the light of pathological parameters, including MMR status. This evidence concerns the gene PDCD1 and neoplasm.